Simplex Trading’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$40.1K 9493
2025
Q4
$40.1K Sell
500
-3,000
-86% -$202K ﹤0.01% 5860
2025
Q3
$170K Sell
3,500
-4,200
-55% -$260K ﹤0.01% 5133
2025
Q2
$574K Buy
7,700
+6,400
+492% +$424K ﹤0.01% 3352
2025
Q1
$82K Sell
1,300
-46,800
-97% -$3.18M ﹤0.01% 5267
2024
Q4
$3.75M Buy
48,100
+47,900
+23,950% +$3.85M ﹤0.01% 1685
2024
Q3
$16K Sell
200
-900
-82% -$72.7K ﹤0.01% 6839
2024
Q2
$91K Sell
1,100
-1,600
-59% -$141K ﹤0.01% 5473
2024
Q1
$230K Buy
2,700
+2,500
+1,250% +$196K ﹤0.01% 4689
2023
Q4
$17K Sell
200
-200
-50% -$17.3K ﹤0.01% 7050
2023
Q3
$35K Buy
+400
New +$35.7K ﹤0.01% 6124
2022
Q4
Sell
-100
Closed -$7K 9650
2022
Q3
$7K Sell
100
-900
-90% -$64.6K ﹤0.01% 8525
2022
Q2
$65K Hold
1,000
﹤0.01% 6147
2022
Q1
$63K Buy
+1,000
New +$54.4K ﹤0.01% 6812
2021
Q4
Sell
-45,900
Closed -$3.11M 10838
2021
Q3
$3.11M Hold
45,900
﹤0.01% 1636
2021
Q2
$3.06M Buy
45,900
+45,526
+12,173% +$3.22M ﹤0.01% 1656
2021
Q1
$4.15M Sell
374
-9
-2% -$1.11K 0.01% 962
2020
Q4
$4.55M Buy
383
+357
+1,373% +$38.4K 0.01% 1051
2020
Q3
$226K Buy
26
+23
+767% +$2.01K ﹤0.01% 3949
2020
Q2
$26K Buy
+3
New +$303 ﹤0.01% 6018
2019
Q1
Sell
-1
Closed -$10K 7376
2018
Q4
$10K Buy
+1
New +$105 ﹤0.01% 5839
2017
Q3
Sell
-18
Closed -$4K 6167
2017
Q2
$4K Sell
18
-9
-33% -$370 ﹤0.01% 4763
2017
Q1
$3K Buy
+27
New +$1.05K ﹤0.01% 4989

Other funds holding HAE

Simplex Trading's HAE Position: Q3 2025 in Review

Simplex Trading sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 2,012 shares — an estimated $125K sold.

Simplex Trading first reported a position in HAE in Q3 2018 and held it in 12 quarters. The position peaked at $1.13M in Q2 2022. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.

  • Simplex Trading reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,012 Haemonetics shares in Q3 2025, an estimated $125K.
  • Simplex Trading first reported a position in Haemonetics in Q3 2018 and held it in 12 quarters.
  • Simplex Trading's Haemonetics position peaked at $1.13M in Q2 2022.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.